Evidence map›Paper›PMID 18983246›Full record

Trial reportThe Journal of infectious diseases2008

Effect of praziquantel treatment during pregnancy on cytokine responses to schistosome antigens: results of a randomized, placebo-controlled trial.

Robert Tweyongyere, Patrice A Mawa, Sophy Ngom-Wegi, Juliet Ndibazza, Trinh Duong, Birgitte J Vennervald, David W Dunne, Eli Katunguka-Rwakishaya, Alison M Elliott

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of infectious diseases, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Drugs for treating Schistosoma mansoni infection.The Cochrane database of systematic reviews · 2013
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Pregnancy and helminth infections.Parasite immunology · 2014
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Robert TweyongyereMedical Research Council/Uganda Virus Research-Institute Uganda Research Unit on AIDS, Entebbe, Uganda. tmrobert966@gmail.com
Patrice A Mawa
Sophy Ngom-Wegi
Juliet Ndibazza
Trinh Duong
Birgitte J Vennervald
David W Dunne
Eli Katunguka-Rwakishaya
Alison M Elliott
Uganda Virus Research Institute · UGLondon School of Hygiene & Tropical Medicine · GBMakerere University · UGUniversity of Cambridge · GBUniversity of Copenhagen · DK

Funding

Medical Research Council G0700837Wellcome Trust 064693Wellcome Trust 079110
6 · The paper itself

Abstract

backgroundPraziquantel treatment of schistosomiasis boosts antischistosome responses, with type 2 helper T cell bias that may contribute to immunologically mediated killing and to protection against reinfection. Praziquantel treatment during pregnancy was recommended in 2002, but the immunological effects of the treatment had not been investigated.

methodsA cohort of 387 Schistosoma mansoni-infected women were recruited from a larger trial of deworming during pregnancy. Women were randomized to receive either praziquantel or placebo during pregnancy. Six weeks after delivery, all women received praziquantel. Cytokine responses to S. mansoni worm and egg antigens were measured in whole blood culture before and 6 weeks after each treatment.

resultsSchistosome-specific cytokine responses were suppressed during pregnancy. Praziquantel treatment during pregnancy caused significant boosts in interferon-gamma (IFN-gamma), interleukin (IL)-2, IL-4, IL-5, IL-13, and IL-10 responses to schistosome worm antigen and in IFN-gamma, IL-5, and IL-13 responses to schistosome egg antigen, but these boosts were not as substantial as those seen for women treated after delivery.

conclusionPregnancy suppresses a potentially beneficial boost in cytokine responses associated with praziquantel treatment. Further studies are needed on the long-term effects that treatment of schistosomiasis during pregnancy have on morbidity and resistance to reinfection among treated women and their offspring.

Indexed as

AdolescentAdultAntigens, HelminthCytokinesFemaleGene Expression ProfilingHumansPraziquantelPregnancySchistosomiasis mansoniSchistosomicidesAntigens, HelminthCytokinesPraziquantelSchistosomicides

Identifiers

PMID18983246
PMCPMC2892302
OpenAlexW2126624098

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.